Latest Administration News

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Boss Energy Limited reported a solid cash flow performance for the September 2025 quarter, ending with nearly A$48 million in unrestricted cash, underpinning its ongoing uranium exploration and development activities.

Tyranna Resources has advanced its exploration and acquisition efforts in Angola, securing a major stake in the Chinguar Gold Project and extending its lithium-caesium project tenure, supported by a solid cash position.

Orthocell has appointed MontsMed as the exclusive distributor for its nerve repair product Remplir™ in Hong Kong, marking a significant step in its Asian commercialisation strategy. This move opens access to the vast Guangdong-Hong Kong-Macao Greater Bay Area, complementing existing operations in Singapore and planned expansion in Thailand.

Carlton Investments reported a slight rise in net profit and an 8.7% increase in dividends for FY2025, while its investment portfolio grew nearly 60% over five years despite recent market fluctuations.

Dimerix Limited reports solid progress in its Phase 3 trial for DMX-200 targeting rare kidney disease FSGS, backed by orphan drug status in Japan and a robust cash position. The company prepares to engage the FDA on new data supporting regulatory approval.

Immutep Limited reports strong progress in its Phase III lung cancer trial with over 170 patients enrolled, alongside positive FDA feedback and a robust cash position supporting ongoing development.

Novo Resources reported a narrowed Q3 2025 net loss amid active exploration in Western Australia and New South Wales, boosted by a significant share sale that enhanced liquidity.

Novo Resources Corp. reported a reduced net loss of CAD 9.7 million for the nine months to September 2025, supported by lower operating cash outflows and a significant post-period sale of San Cristobel Mining shares. The company maintains a cautious outlook amid ongoing funding needs.

Triangle Energy (Global) Limited has amended its quarterly cash flow report to correct key figures while advancing new permits in the Philippines and progressing the transition of its Cliff Head Oil Field to a carbon capture and storage project.

Jatcorp’s Q1 FY26 revenue dipped 8% following a record Q4, yet the company advanced key growth initiatives including Southeast Asia expansion and a leadership change.

Freehill Mining Limited has addressed an ASX query over the late filing of a director’s interest notice, attributing the delay to an administrative oversight and reaffirming its compliance protocols.